About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
09:30 Benvinguda i Inauguració Josep Samitier · Coordinador Científic de NANOMED Spain Begoña Benito · Directora del VHIR 09:40 Nanomedicina i càncer Josep Samitier · Coordinador Científic de NANOMED Spain 10:00 Fernanda Raquel Da Silva Andrade · Principal Investigator de Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Research Group, VHIR 10:25 Iván Ramos · CEO Polar NanoPharma 10:50 Cafè 11:20 Esther Vázquez · Applied Proteomics and Protein Engineering, Institut de Biotecnologia i Biomedicina, UAB 11:45 Víctor Puntes, ICREA Research Professor, Head of Pharmacokinetic Nanoparticle Research group VHIR and Group Leader at ICN2 12:10 Sofia Cabezudo · Gestora de projectes Associació Espanyola contra el Càncer 12:30 Clausura
Inscripció: https://nanomedspain.net/ndcc-2025/
